Science

Prerna Mewawalla: Excited to Share our Multicenter Study on Real-world Outcomes of Sequential BCMA Therapies in RRMM After Belantamab

Prerna Mewawalla/LinkedIn

Jun 25, 2025, 09:58

Prerna Mewawalla: Excited to Share our Multicenter Study on Real-world Outcomes of Sequential BCMA Therapies in RRMM After Belantamab

Prerna Mewawalla, Myeloma and Transplant Physician, Associate Professor at Drexel University, shared a post on X:

“Excited to share our multicenter study just published in Clinical Lymphoma, Myeloma and Leukemia:

Title: Real-World Outcomes of Sequential BCMA-directed therapies inRelapsed Refractory Multiple Myeloma After Belantamab Exposure

Authors: Prerna Mewawalla, Rachel Dileo, Yue Yin, Christopher Strouse, Hira Shaikh, James A Davis, Omar Alkharabsheh, Aliya Rashid, Nausheen Ahmed, Al-Ola Abdallah, Hamza Hashmi

You can read the Full Article on Clinical Lymphoma, Myeloma and Leukemia

Prerna Mewawalla: Excited to Share our Multicenter Study on Real-world Outcomes of Sequential BCMA Therapies in RRMM After Belantamab

Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared this post, adding:

“Congrats Prerna Mewawalla and all group on current publication ‘Real-world outcomes of sequential BCMA therapies in RRMM after belantamab”

More posts featuring Prerna Mewawalla

Al-Ola Abdallah Aliya Rashid BCMA therapies belantamab cancer Christopher Strouse Clinical Lymphoma Hamza Hashmi Hira Shaikh James A. Davis Myeloma and Leukemia Nausheen Ahmed Omar Alkharabsheh OncoDaily Oncology Prerna Mewawalla Rachel Dileo Yue Yin

BEATcc Trial at ESMOGynaec25: Atezolizumab Benefits Cervical Cancer Patients Regardless of PD-L1 Status

15 Posts Not to Miss from EACR 2025

ASCO 2025 RCC Advances: Expert Insights by Ilya Tsimafeyeu

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself